Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.64613067 |
2 | negative regulation of cell killing (GO:0031342) | 5.14568120 |
3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.14568120 |
4 | definitive hemopoiesis (GO:0060216) | 4.92048729 |
5 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.80658004 |
6 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.71316741 |
7 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.64114316 |
8 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.64114316 |
9 | megakaryocyte development (GO:0035855) | 4.57498634 |
10 | negative regulation of phagocytosis (GO:0050765) | 4.51456655 |
11 | interferon-gamma production (GO:0032609) | 4.49577616 |
12 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.33496092 |
13 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.27967205 |
14 | mast cell activation (GO:0045576) | 4.20149522 |
15 | positive regulation of B cell differentiation (GO:0045579) | 4.09147542 |
16 | negative T cell selection (GO:0043383) | 3.97755844 |
17 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.96414032 |
18 | regulation of B cell differentiation (GO:0045577) | 3.95263986 |
19 | negative thymic T cell selection (GO:0045060) | 3.85379518 |
20 | regulation of gamma-delta T cell activation (GO:0046643) | 3.75434687 |
21 | B cell receptor signaling pathway (GO:0050853) | 3.74305028 |
22 | response to interleukin-15 (GO:0070672) | 3.64084459 |
23 | hepatocyte apoptotic process (GO:0097284) | 3.59149067 |
24 | cellular response to interleukin-15 (GO:0071350) | 3.57111225 |
25 | neutrophil activation involved in immune response (GO:0002283) | 3.50231489 |
26 | positive thymic T cell selection (GO:0045059) | 3.48495643 |
27 | T cell migration (GO:0072678) | 3.48457923 |
28 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.45801035 |
29 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.42861153 |
30 | mast cell activation involved in immune response (GO:0002279) | 3.42072272 |
31 | mast cell degranulation (GO:0043303) | 3.42072272 |
32 | leukocyte aggregation (GO:0070486) | 3.40290267 |
33 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.37969044 |
34 | positive regulation of granulocyte differentiation (GO:0030854) | 3.33386708 |
35 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.30966586 |
36 | myeloid dendritic cell activation (GO:0001773) | 3.23483899 |
37 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.22325809 |
38 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.17525132 |
39 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.17297655 |
40 | pinocytosis (GO:0006907) | 3.15963654 |
41 | positive T cell selection (GO:0043368) | 3.15723500 |
42 | detection of other organism (GO:0098543) | 3.15501735 |
43 | macrophage activation involved in immune response (GO:0002281) | 3.14338989 |
44 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.12964813 |
45 | regulation of platelet aggregation (GO:0090330) | 3.12031307 |
46 | angiogenesis involved in wound healing (GO:0060055) | 3.11027974 |
47 | dendritic cell chemotaxis (GO:0002407) | 3.10557009 |
48 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.09097380 |
49 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.09097380 |
50 | modulation by symbiont of host immune response (GO:0052553) | 3.09097380 |
51 | positive regulation by symbiont of host defense response (GO:0052509) | 3.09097380 |
52 | modulation by symbiont of host defense response (GO:0052031) | 3.09097380 |
53 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.09097380 |
54 | negative regulation of B cell proliferation (GO:0030889) | 3.09074149 |
55 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.08470942 |
56 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.08026580 |
57 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.08026580 |
58 | response to protozoan (GO:0001562) | 3.04390438 |
59 | defense response to protozoan (GO:0042832) | 3.03273576 |
60 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.02876890 |
61 | positive regulation of interferon-alpha production (GO:0032727) | 3.02844918 |
62 | myeloid cell activation involved in immune response (GO:0002275) | 3.02272300 |
63 | T cell homeostasis (GO:0043029) | 3.01862002 |
64 | neutrophil activation (GO:0042119) | 3.01131772 |
65 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.01018192 |
66 | response to peptidoglycan (GO:0032494) | 3.00444615 |
67 | dendritic cell migration (GO:0036336) | 2.98866562 |
68 | negative regulation of interleukin-12 production (GO:0032695) | 2.98842228 |
69 | positive regulation of isotype switching (GO:0045830) | 2.97885166 |
70 | negative regulation of T cell mediated immunity (GO:0002710) | 2.95882624 |
71 | B cell homeostasis (GO:0001782) | 2.94788947 |
72 | microglial cell activation (GO:0001774) | 2.94664095 |
73 | necroptotic process (GO:0070266) | 2.93806581 |
74 | embryonic hemopoiesis (GO:0035162) | 2.93336213 |
75 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.93240582 |
76 | regulation of response to interferon-gamma (GO:0060330) | 2.93095359 |
77 | regulation of interferon-alpha production (GO:0032647) | 2.93084568 |
78 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.92634164 |
79 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.92603659 |
80 | cellular extravasation (GO:0045123) | 2.91361816 |
81 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.91265703 |
82 | leukocyte degranulation (GO:0043299) | 2.90872872 |
83 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.90736278 |
84 | regulation of regulatory T cell differentiation (GO:0045589) | 2.90290528 |
85 | detection of bacterium (GO:0016045) | 2.89462561 |
86 | regulation of granulocyte differentiation (GO:0030852) | 2.88166421 |
87 | positive regulation of macrophage differentiation (GO:0045651) | 2.86494560 |
88 | T cell selection (GO:0045058) | 2.85712750 |
89 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.85624393 |
90 | thymic T cell selection (GO:0045061) | 2.85166615 |
91 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.84973171 |
92 | regulation of necroptotic process (GO:0060544) | 2.84616533 |
93 | detection of molecule of bacterial origin (GO:0032490) | 2.84473698 |
94 | response to type I interferon (GO:0034340) | 2.83779087 |
95 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.83289609 |
96 | activated T cell proliferation (GO:0050798) | 2.82044832 |
97 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.81151480 |
98 | lymphocyte homeostasis (GO:0002260) | 2.80011868 |
99 | germinal center formation (GO:0002467) | 2.79032067 |
100 | cellular response to type I interferon (GO:0071357) | 2.78477363 |
101 | type I interferon signaling pathway (GO:0060337) | 2.78477363 |
102 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.78363983 |
103 | lymph node development (GO:0048535) | 2.78340150 |
104 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.78123918 |
105 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.77868396 |
106 | detection of external biotic stimulus (GO:0098581) | 2.77792702 |
107 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.77682835 |
108 | T cell proliferation (GO:0042098) | 2.76352669 |
109 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.76338387 |
110 | positive regulation of DNA recombination (GO:0045911) | 2.76017381 |
111 | myeloid leukocyte activation (GO:0002274) | 2.74209531 |
112 | positive regulation of mast cell activation (GO:0033005) | 2.73179170 |
113 | regulation of tolerance induction (GO:0002643) | 2.72773125 |
114 | immunoglobulin mediated immune response (GO:0016064) | 2.71743040 |
115 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.69101635 |
116 | tolerance induction (GO:0002507) | 2.69027579 |
117 | response to muramyl dipeptide (GO:0032495) | 2.68979206 |
118 | T cell receptor signaling pathway (GO:0050852) | 2.68937598 |
119 | granulocyte activation (GO:0036230) | 2.67768913 |
120 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.67600198 |
121 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.67243257 |
122 | response to host immune response (GO:0052572) | 2.67243257 |
123 | respiratory burst (GO:0045730) | 2.66089014 |
124 | cellular response to interferon-beta (GO:0035458) | 2.65255280 |
125 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.64743732 |
126 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.64743732 |
127 | response to host (GO:0075136) | 2.64100439 |
128 | response to host defenses (GO:0052200) | 2.64100439 |
129 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.64100439 |
130 | regulation of T cell tolerance induction (GO:0002664) | 2.62145844 |
131 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.60740078 |
132 | positive regulation of tolerance induction (GO:0002645) | 2.59814679 |
133 | regulation of B cell mediated immunity (GO:0002712) | 2.59356652 |
134 | B cell proliferation (GO:0042100) | 2.59182825 |
135 | ribosomal small subunit assembly (GO:0000028) | 2.57699974 |
136 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.57509658 |
137 | regulation of mast cell degranulation (GO:0043304) | 2.57399267 |
138 | cellular response to ethanol (GO:0071361) | 2.55770244 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.31331278 |
2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.68326365 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.61127243 |
4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.49557317 |
5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.93898734 |
6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.85187962 |
7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.65540232 |
8 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.61179550 |
9 | * SCL_19346495_ChIP-Seq_HPC-7_Human | 3.09239148 |
10 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.05641827 |
11 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.97452162 |
12 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.88736668 |
13 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.79873002 |
14 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.79568178 |
15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.66998260 |
16 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 2.57445902 |
17 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.57289040 |
18 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.52708618 |
19 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.52233471 |
20 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.51926481 |
21 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.46899218 |
22 | * MYB_26560356_Chip-Seq_TH2_Human | 2.41260674 |
23 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.31145180 |
24 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.29738703 |
25 | GATA1_22025678_ChIP-Seq_K562_Human | 2.24238330 |
26 | MYB_26560356_Chip-Seq_TH1_Human | 2.16447542 |
27 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.12058228 |
28 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.06090984 |
29 | MAF_26560356_Chip-Seq_TH1_Human | 1.91626254 |
30 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.90823564 |
31 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.90797992 |
32 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.84725575 |
33 | MYC_22102868_ChIP-Seq_BL_Human | 1.81450139 |
34 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.78865063 |
35 | * E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.78860920 |
36 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75634660 |
37 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.72567473 |
38 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.67703648 |
39 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65734038 |
40 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.63338746 |
41 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.60727886 |
42 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.59449009 |
43 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58907910 |
44 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56515674 |
45 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.56343672 |
46 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.50737004 |
47 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.48801323 |
48 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.47474896 |
49 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.47215346 |
50 | UTX_26944678_Chip-Seq_JUKART_Human | 1.46061251 |
51 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.45773675 |
52 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.44011891 |
53 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.43430575 |
54 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.38401539 |
55 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.34416766 |
56 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.32120074 |
57 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.30369137 |
58 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.29902626 |
59 | GATA3_26560356_Chip-Seq_TH2_Human | 1.25909249 |
60 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.23313923 |
61 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.23239454 |
62 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.22838358 |
63 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.22538318 |
64 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.22056543 |
65 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.21539871 |
66 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.20863264 |
67 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.17493469 |
68 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.16299028 |
69 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.14988899 |
70 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.14734001 |
71 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.13702694 |
72 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.12822819 |
73 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.11843498 |
74 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.11793289 |
75 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.11654723 |
76 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.11338833 |
77 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.11312439 |
78 | * E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.10752695 |
79 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.08411447 |
80 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04694321 |
81 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.04228661 |
82 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02899320 |
83 | MAF_26560356_Chip-Seq_TH2_Human | 1.01839876 |
84 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.00796721 |
85 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99514360 |
86 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99355299 |
87 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.97323950 |
88 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96496059 |
89 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.95804072 |
90 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95611431 |
91 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.93703353 |
92 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.92784856 |
93 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.92690524 |
94 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.90433304 |
95 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.89159939 |
96 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.88154808 |
97 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.87331153 |
98 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.86734776 |
99 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.85531007 |
100 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.85224279 |
101 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.82975939 |
102 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.81761466 |
103 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.80706692 |
104 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.79481970 |
105 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.79453011 |
106 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.79217983 |
107 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.78374088 |
108 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.77768090 |
109 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.77670441 |
110 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.77478749 |
111 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.77318441 |
112 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.77318441 |
113 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76750744 |
114 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.76345609 |
115 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.75814852 |
116 | GATA2_19941826_ChIP-Seq_K562_Human | 0.75214119 |
117 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.74972127 |
118 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.74813690 |
119 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.74381710 |
120 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.73715671 |
121 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.73505274 |
122 | GATA1_19941826_ChIP-Seq_K562_Human | 0.72439464 |
123 | * SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.72283008 |
124 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.70278275 |
125 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.69961728 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 4.25238755 |
2 | MP0002396_abnormal_hematopoietic_system | 3.54002455 |
3 | MP0003763_abnormal_thymus_physiology | 3.19910261 |
4 | MP0005671_abnormal_response_to | 3.19053093 |
5 | MP0001800_abnormal_humoral_immune | 2.73655228 |
6 | MP0005000_abnormal_immune_tolerance | 2.62113516 |
7 | MP0009785_altered_susceptibility_to | 2.61443135 |
8 | MP0002166_altered_tumor_susceptibility | 2.60600167 |
9 | MP0002452_abnormal_antigen_presenting | 2.53403903 |
10 | MP0003436_decreased_susceptibility_to | 2.49884582 |
11 | MP0005464_abnormal_platelet_physiology | 2.48504060 |
12 | MP0002420_abnormal_adaptive_immunity | 2.46917898 |
13 | MP0001819_abnormal_immune_cell | 2.45057536 |
14 | MP0002723_abnormal_immune_serum | 2.43048390 |
15 | MP0002419_abnormal_innate_immunity | 2.41198154 |
16 | MP0001790_abnormal_immune_system | 2.40225778 |
17 | MP0005387_immune_system_phenotype | 2.40225778 |
18 | MP0002398_abnormal_bone_marrow | 2.39610895 |
19 | MP0005025_abnormal_response_to | 2.35282781 |
20 | MP0000685_abnormal_immune_system | 2.34848723 |
21 | MP0002148_abnormal_hypersensitivity_rea | 2.32170038 |
22 | MP0004808_abnormal_hematopoietic_stem | 2.24359721 |
23 | MP0003724_increased_susceptibility_to | 2.21956898 |
24 | MP0002006_tumorigenesis | 2.11552439 |
25 | MP0000716_abnormal_immune_system | 2.07967885 |
26 | MP0000689_abnormal_spleen_morphology | 2.03766988 |
27 | MP0005397_hematopoietic_system_phenotyp | 2.02102408 |
28 | MP0001545_abnormal_hematopoietic_system | 2.02102408 |
29 | MP0000465_gastrointestinal_hemorrhage | 1.96802679 |
30 | MP0005174_abnormal_tail_pigmentation | 1.96374881 |
31 | MP0001853_heart_inflammation | 1.94860116 |
32 | MP0002405_respiratory_system_inflammati | 1.94687534 |
33 | MP0002722_abnormal_immune_system | 1.89889781 |
34 | MP0000569_abnormal_digit_pigmentation | 1.88339957 |
35 | MP0006082_CNS_inflammation | 1.85003562 |
36 | MP0009333_abnormal_splenocyte_physiolog | 1.81863856 |
37 | MP0002429_abnormal_blood_cell | 1.80691906 |
38 | MP0005075_abnormal_melanosome_morpholog | 1.76391015 |
39 | MP0000703_abnormal_thymus_morphology | 1.74609553 |
40 | MP0006054_spinal_hemorrhage | 1.73829674 |
41 | MP0010155_abnormal_intestine_physiology | 1.71343320 |
42 | MP0001873_stomach_inflammation | 1.70665216 |
43 | MP0008057_abnormal_DNA_replication | 1.67383805 |
44 | MP0003300_gastrointestinal_ulcer | 1.66098635 |
45 | MP0005451_abnormal_body_composition | 1.65552850 |
46 | MP0001845_abnormal_inflammatory_respons | 1.52210691 |
47 | MP0000015_abnormal_ear_pigmentation | 1.49340292 |
48 | MP0000858_altered_metastatic_potential | 1.47777192 |
49 | MP0000490_abnormal_crypts_of | 1.43862665 |
50 | MP0004130_abnormal_muscle_cell | 1.39647116 |
51 | MP0003091_abnormal_cell_migration | 1.39310248 |
52 | MP0008260_abnormal_autophagy | 1.38317689 |
53 | MP0004947_skin_inflammation | 1.37170337 |
54 | MP0002009_preneoplasia | 1.33459062 |
55 | MP0008007_abnormal_cellular_replicative | 1.33193112 |
56 | MP0003866_abnormal_defecation | 1.32931150 |
57 | MP0010094_abnormal_chromosome_stability | 1.29486986 |
58 | MP0008004_abnormal_stomach_pH | 1.29125159 |
59 | MP0002132_abnormal_respiratory_system | 1.28908905 |
60 | MP0001533_abnormal_skeleton_physiology | 1.27312366 |
61 | MP0002095_abnormal_skin_pigmentation | 1.26922231 |
62 | MP0004147_increased_porphyrin_level | 1.22164434 |
63 | MP0003303_peritoneal_inflammation | 1.22044040 |
64 | MP0004883_abnormal_blood_vessel | 1.21842034 |
65 | MP0002933_joint_inflammation | 1.20240424 |
66 | MP0005409_darkened_coat_color | 1.16828251 |
67 | MP0008469_abnormal_protein_level | 1.13718828 |
68 | MP0003172_abnormal_lysosome_physiology | 1.12018475 |
69 | MP0009764_decreased_sensitivity_to | 1.10892336 |
70 | MP0003183_abnormal_peptide_metabolism | 1.10607705 |
71 | MP0005058_abnormal_lysosome_morphology | 1.10568805 |
72 | MP0003943_abnormal_hepatobiliary_system | 1.09845508 |
73 | MP0003448_altered_tumor_morphology | 1.08513485 |
74 | MP0004381_abnormal_hair_follicle | 1.02938925 |
75 | MP0005164_abnormal_response_to | 0.99832944 |
76 | MP0002019_abnormal_tumor_incidence | 0.99064159 |
77 | MP0009278_abnormal_bone_marrow | 0.98887348 |
78 | MP0000249_abnormal_blood_vessel | 0.98864068 |
79 | MP0004036_abnormal_muscle_relaxation | 0.98657956 |
80 | MP0001986_abnormal_taste_sensitivity | 0.98552624 |
81 | MP0004484_altered_response_of | 0.96291520 |
82 | MP0003656_abnormal_erythrocyte_physiolo | 0.96290589 |
83 | MP0000343_altered_response_to | 0.96166665 |
84 | MP0002332_abnormal_exercise_endurance | 0.94720236 |
85 | MP0010307_abnormal_tumor_latency | 0.94686169 |
86 | MP0005310_abnormal_salivary_gland | 0.94562419 |
87 | MP0010352_gastrointestinal_tract_polyps | 0.93954073 |
88 | MP0004084_abnormal_cardiac_muscle | 0.93835455 |
89 | MP0002877_abnormal_melanocyte_morpholog | 0.93671341 |
90 | MP0003077_abnormal_cell_cycle | 0.91350815 |
91 | MP0001958_emphysema | 0.90343167 |
92 | MP0002998_abnormal_bone_remodeling | 0.89475310 |
93 | MP0000371_diluted_coat_color | 0.84772233 |
94 | MP0001851_eye_inflammation | 0.83051624 |
95 | MP0004782_abnormal_surfactant_physiolog | 0.80168315 |
96 | MP0005166_decreased_susceptibility_to | 0.80160677 |
97 | MP0004185_abnormal_adipocyte_glucose | 0.77046612 |
98 | MP0009763_increased_sensitivity_to | 0.76936639 |
99 | MP0003221_abnormal_cardiomyocyte_apopto | 0.76855868 |
100 | MP0003279_aneurysm | 0.76289802 |
101 | MP0003828_pulmonary_edema | 0.76107224 |
102 | MP0008058_abnormal_DNA_repair | 0.75631764 |
103 | MP0003693_abnormal_embryo_hatching | 0.72391171 |
104 | MP0003045_fibrosis | 0.70869016 |
105 | MP0003191_abnormal_cellular_cholesterol | 0.70194554 |
106 | MP0004510_myositis | 0.70115085 |
107 | MP0005666_abnormal_adipose_tissue | 0.69090787 |
108 | MP0000372_irregular_coat_pigmentation | 0.68898485 |
109 | MP0005390_skeleton_phenotype | 0.67141390 |
110 | MP0001663_abnormal_digestive_system | 0.66434898 |
111 | MP0003795_abnormal_bone_structure | 0.66354458 |
112 | MP0003075_altered_response_to | 0.66143697 |
113 | MP0009115_abnormal_fat_cell | 0.65564350 |
114 | MP0003566_abnormal_cell_adhesion | 0.65278625 |
115 | MP0002075_abnormal_coat/hair_pigmentati | 0.64793294 |
116 | MP0001243_abnormal_dermal_layer | 0.64518315 |
117 | MP0002060_abnormal_skin_morphology | 0.63154937 |
118 | MP0001191_abnormal_skin_condition | 0.62770855 |
119 | MP0003111_abnormal_nucleus_morphology | 0.62210437 |
120 | MP0005621_abnormal_cell_physiology | 0.62171904 |
121 | MP0005023_abnormal_wound_healing | 0.61856853 |
122 | MP0001186_pigmentation_phenotype | 0.59988887 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 4.47654423 |
2 | Myositis (HP:0100614) | 4.09506860 |
3 | Recurrent viral infections (HP:0004429) | 4.06656483 |
4 | Recurrent bacterial skin infections (HP:0005406) | 4.01329229 |
5 | T lymphocytopenia (HP:0005403) | 4.00792176 |
6 | Abnormality of T cell number (HP:0011839) | 3.82753933 |
7 | Eczematoid dermatitis (HP:0000976) | 3.77118207 |
8 | Thrombocytosis (HP:0001894) | 3.71809117 |
9 | Recurrent fungal infections (HP:0002841) | 3.67059310 |
10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.65947495 |
11 | IgM deficiency (HP:0002850) | 3.62240801 |
12 | Chronic otitis media (HP:0000389) | 3.47596031 |
13 | Abnormality of T cells (HP:0002843) | 3.38814925 |
14 | Abnormality of the fingertips (HP:0001211) | 3.37610255 |
15 | Optic neuritis (HP:0100653) | 3.35679050 |
16 | Retrobulbar optic neuritis (HP:0100654) | 3.35679050 |
17 | Abnormality of the prostate (HP:0008775) | 3.34337756 |
18 | Autoimmune hemolytic anemia (HP:0001890) | 3.31729584 |
19 | Meningitis (HP:0001287) | 3.31216647 |
20 | Panhypogammaglobulinemia (HP:0003139) | 3.26970527 |
21 | Agammaglobulinemia (HP:0004432) | 3.14156218 |
22 | Spinal cord lesions (HP:0100561) | 3.11376463 |
23 | Syringomyelia (HP:0003396) | 3.11376463 |
24 | Orchitis (HP:0100796) | 3.10905369 |
25 | Prolonged bleeding time (HP:0003010) | 3.09704673 |
26 | Gastrointestinal infarctions (HP:0005244) | 3.08289818 |
27 | Thyroiditis (HP:0100646) | 3.05886273 |
28 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.99267877 |
29 | Keratoconjunctivitis sicca (HP:0001097) | 2.97893784 |
30 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.96484925 |
31 | Recurrent cutaneous fungal infections (HP:0011370) | 2.96484925 |
32 | Petechiae (HP:0000967) | 2.93990420 |
33 | Recurrent bronchitis (HP:0002837) | 2.93789102 |
34 | Spontaneous hematomas (HP:0007420) | 2.93507750 |
35 | Recurrent skin infections (HP:0001581) | 2.92460761 |
36 | Vasculitis (HP:0002633) | 2.91239025 |
37 | Epistaxis (HP:0000421) | 2.90332533 |
38 | Mediastinal lymphadenopathy (HP:0100721) | 2.88640442 |
39 | Abnormality of T cell physiology (HP:0011840) | 2.84574896 |
40 | Encephalitis (HP:0002383) | 2.84132018 |
41 | Cellulitis (HP:0100658) | 2.82836623 |
42 | Obstructive lung disease (HP:0006536) | 2.77206762 |
43 | Chronic obstructive pulmonary disease (HP:0006510) | 2.77206762 |
44 | Menorrhagia (HP:0000132) | 2.74400854 |
45 | Absent frontal sinuses (HP:0002688) | 2.72508295 |
46 | Arterial thrombosis (HP:0004420) | 2.71694408 |
47 | Chromsome breakage (HP:0040012) | 2.68287999 |
48 | Periodontitis (HP:0000704) | 2.68209825 |
49 | Keratoconjunctivitis (HP:0001096) | 2.67768355 |
50 | Severe combined immunodeficiency (HP:0004430) | 2.65135583 |
51 | Lymphopenia (HP:0001888) | 2.62511703 |
52 | Fatigue (HP:0012378) | 2.61937955 |
53 | IgG deficiency (HP:0004315) | 2.61808961 |
54 | Eosinophilia (HP:0001880) | 2.57937868 |
55 | Chronic diarrhea (HP:0002028) | 2.56117134 |
56 | Leukocytosis (HP:0001974) | 2.54913872 |
57 | Abnormality of eosinophils (HP:0001879) | 2.54292562 |
58 | Acute myeloid leukemia (HP:0004808) | 2.53207767 |
59 | B lymphocytopenia (HP:0010976) | 2.50940374 |
60 | Abnormality of B cell number (HP:0010975) | 2.50940374 |
61 | Pulmonary infiltrates (HP:0002113) | 2.45676435 |
62 | Osteomyelitis (HP:0002754) | 2.44902683 |
63 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.44216632 |
64 | Abnormal platelet volume (HP:0011876) | 2.41633135 |
65 | Granulocytopenia (HP:0001913) | 2.40915692 |
66 | Lymphoma (HP:0002665) | 2.39204242 |
67 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.38390914 |
68 | Inflammation of the large intestine (HP:0002037) | 2.36520194 |
69 | IgA deficiency (HP:0002720) | 2.36169349 |
70 | Viral hepatitis (HP:0006562) | 2.36063773 |
71 | Papilledema (HP:0001085) | 2.35071751 |
72 | Prostate neoplasm (HP:0100787) | 2.33098504 |
73 | Combined immunodeficiency (HP:0005387) | 2.32438049 |
74 | Gingival bleeding (HP:0000225) | 2.30911094 |
75 | Hemoptysis (HP:0002105) | 2.30154716 |
76 | Purpura (HP:0000979) | 2.29627455 |
77 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.27207358 |
78 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.25985621 |
79 | Nemaline bodies (HP:0003798) | 2.25917412 |
80 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.24690079 |
81 | Autoimmune thrombocytopenia (HP:0001973) | 2.24209327 |
82 | Conjunctival telangiectasia (HP:0000524) | 2.24173328 |
83 | Gastrointestinal inflammation (HP:0004386) | 2.21536178 |
84 | Verrucae (HP:0200043) | 2.21120763 |
85 | Papilloma (HP:0012740) | 2.21120763 |
86 | Myelodysplasia (HP:0002863) | 2.20003631 |
87 | Increased IgE level (HP:0003212) | 2.19473786 |
88 | Aplastic anemia (HP:0001915) | 2.18262811 |
89 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.18174805 |
90 | Abnormal hair whorl (HP:0010721) | 2.15888196 |
91 | Pustule (HP:0200039) | 2.15019942 |
92 | Abnormality of macrophages (HP:0004311) | 2.14766687 |
93 | Aortic aneurysm (HP:0004942) | 2.14307189 |
94 | Hypoplasia of the thymus (HP:0000778) | 2.12025491 |
95 | Muscle fiber inclusion bodies (HP:0100299) | 2.10961527 |
96 | Urticaria (HP:0001025) | 2.09849369 |
97 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.09660247 |
98 | Polycythemia (HP:0001901) | 2.08993537 |
99 | Amaurosis fugax (HP:0100576) | 2.08174954 |
100 | Clubbing of toes (HP:0100760) | 2.07892537 |
101 | Osteolytic defects of the hand bones (HP:0009699) | 2.06711495 |
102 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.06711495 |
103 | Abnormal platelet function (HP:0011869) | 2.05993232 |
104 | Impaired platelet aggregation (HP:0003540) | 2.05993232 |
105 | Pulmonary embolism (HP:0002204) | 2.05015576 |
106 | Long clavicles (HP:0000890) | 2.04482678 |
107 | Chest pain (HP:0100749) | 2.03124537 |
108 | Increased IgM level (HP:0003496) | 2.01523833 |
109 | Spondylolisthesis (HP:0003302) | 2.00935991 |
110 | Gingivitis (HP:0000230) | 2.00747494 |
111 | Subacute progressive viral hepatitis (HP:0006572) | 2.00155431 |
112 | Stomatitis (HP:0010280) | 1.99890098 |
113 | Colitis (HP:0002583) | 1.99746067 |
114 | Joint swelling (HP:0001386) | 1.98802021 |
115 | Hematochezia (HP:0002573) | 1.98233087 |
116 | Recurrent pneumonia (HP:0006532) | 1.98218088 |
117 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.97795185 |
118 | Increased cerebral lipofuscin (HP:0011813) | 1.96955141 |
119 | Peritonitis (HP:0002586) | 1.96919248 |
120 | Abnormality of the frontal sinuses (HP:0002687) | 1.96686964 |
121 | Keratitis (HP:0000491) | 1.96674092 |
122 | Volvulus (HP:0002580) | 1.96336380 |
123 | Increased mean platelet volume (HP:0011877) | 1.95645607 |
124 | Abnormality of the pleura (HP:0002103) | 1.92275252 |
125 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.92105509 |
126 | Poikilocytosis (HP:0004447) | 1.91456634 |
127 | Gastrointestinal stroma tumor (HP:0100723) | 1.89909572 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 4.11993571 |
2 | TXK | 4.09431548 |
3 | TEC | 2.96661872 |
4 | MAP3K14 | 2.81343415 |
5 | KIT | 2.72417092 |
6 | PRPF4B | 2.62705637 |
7 | IRAK4 | 2.55459087 |
8 | JAK3 | 2.43949548 |
9 | ITK | 2.34900147 |
10 | NEK9 | 2.23508261 |
11 | CLK1 | 2.16103663 |
12 | BTK | 2.15041805 |
13 | ZAP70 | 2.14743470 |
14 | BMPR2 | 2.02749090 |
15 | TRPM7 | 1.97413162 |
16 | TYK2 | 1.93279125 |
17 | IKBKE | 1.88400321 |
18 | STK10 | 1.86000420 |
19 | MAP2K3 | 1.83450152 |
20 | SYK | 1.76871598 |
21 | JAK1 | 1.70759806 |
22 | CSF1R | 1.67595639 |
23 | TAOK3 | 1.62473869 |
24 | TGFBR2 | 1.56654698 |
25 | BLK | 1.51441186 |
26 | IRAK3 | 1.50425555 |
27 | IKBKB | 1.46105734 |
28 | FGFR3 | 1.43997945 |
29 | CAMKK2 | 1.42545239 |
30 | TBK1 | 1.40711442 |
31 | LCK | 1.38582436 |
32 | ERN1 | 1.36053279 |
33 | NLK | 1.32863313 |
34 | BRSK2 | 1.29763802 |
35 | FLT3 | 1.26806430 |
36 | PIM1 | 1.25776563 |
37 | CSK | 1.23100583 |
38 | CHUK | 1.21038127 |
39 | SIK3 | 1.16889622 |
40 | HCK | 1.14836693 |
41 | STK4 | 1.12354930 |
42 | ZAK | 1.12001893 |
43 | LYN | 1.11914021 |
44 | CDK12 | 1.10859548 |
45 | MKNK1 | 1.03754821 |
46 | MST4 | 1.03552839 |
47 | NUAK1 | 1.02344685 |
48 | MAP3K10 | 0.98158863 |
49 | FGFR4 | 0.97758829 |
50 | MAPK12 | 0.92654776 |
51 | NME2 | 0.91301066 |
52 | MARK3 | 0.89902312 |
53 | IRAK1 | 0.89870482 |
54 | RPS6KA4 | 0.89163305 |
55 | PDK1 | 0.86144454 |
56 | PIK3CG | 0.84706347 |
57 | FGR | 0.84365367 |
58 | OBSCN | 0.84112501 |
59 | MAP3K1 | 0.83810177 |
60 | MAP3K3 | 0.83587662 |
61 | MAPK11 | 0.81674847 |
62 | STK24 | 0.81430807 |
63 | GRK6 | 0.81147948 |
64 | EPHB1 | 0.80405164 |
65 | FES | 0.79429933 |
66 | MAP3K6 | 0.78676913 |
67 | ATR | 0.78112635 |
68 | RPS6KA6 | 0.77305415 |
69 | TNK2 | 0.75910569 |
70 | PIM2 | 0.75731454 |
71 | PTK2B | 0.75462840 |
72 | TGFBR1 | 0.75096540 |
73 | MAP3K2 | 0.74380634 |
74 | PRKCQ | 0.73065975 |
75 | KSR2 | 0.72362037 |
76 | MKNK2 | 0.70531207 |
77 | CDK6 | 0.70173510 |
78 | SCYL2 | 0.68458673 |
79 | YES1 | 0.65076708 |
80 | RIPK4 | 0.64677755 |
81 | MAPKAPK5 | 0.63665501 |
82 | MAP3K7 | 0.63256556 |
83 | WNK1 | 0.62717542 |
84 | EIF2AK1 | 0.62223356 |
85 | ACVR1B | 0.61226979 |
86 | TTN | 0.60928273 |
87 | FRK | 0.60060372 |
88 | MATK | 0.59794602 |
89 | JAK2 | 0.59497922 |
90 | EEF2K | 0.59263138 |
91 | RPS6KL1 | 0.57656449 |
92 | RPS6KC1 | 0.57656449 |
93 | VRK1 | 0.55935687 |
94 | CDC7 | 0.55516128 |
95 | PDGFRB | 0.54775225 |
96 | PDPK1 | 0.54270268 |
97 | CDK8 | 0.54173372 |
98 | GRK7 | 0.54013825 |
99 | TRIB3 | 0.53981165 |
100 | MAP3K12 | 0.53707826 |
101 | MYLK | 0.53261543 |
102 | TIE1 | 0.53105014 |
103 | MELK | 0.52973017 |
104 | MARK2 | 0.51758183 |
105 | CAMKK1 | 0.51388081 |
106 | MAP3K13 | 0.50807277 |
107 | RPS6KA5 | 0.50762523 |
108 | CDK9 | 0.50702665 |
109 | RAF1 | 0.50273199 |
110 | RET | 0.50153879 |
111 | PASK | 0.49186909 |
112 | HIPK2 | 0.48865124 |
113 | SGK2 | 0.47497487 |
114 | IRAK2 | 0.47368807 |
115 | ERBB3 | 0.46726025 |
116 | RPS6KB2 | 0.46040191 |
117 | SGK3 | 0.45474851 |
118 | BRD4 | 0.45236022 |
119 | EIF2AK2 | 0.43650787 |
120 | CDC42BPA | 0.42958466 |
121 | MAPK4 | 0.42570271 |
122 | MAPKAPK2 | 0.42434218 |
123 | CDK4 | 0.40448588 |
124 | MAP2K6 | 0.40027158 |
125 | TAOK2 | 0.39943553 |
126 | BMX | 0.39360384 |
127 | FYN | 0.38995401 |
128 | PRKCD | 0.38492248 |
129 | EPHA3 | 0.38274611 |
130 | LRRK2 | 0.38248395 |
131 | MAPK3 | 0.37814732 |
132 | GRK5 | 0.37702782 |
133 | RPS6KB1 | 0.37620640 |
134 | MOS | 0.35861606 |
135 | MAP3K5 | 0.35758402 |
136 | GRK1 | 0.35544186 |
137 | MAPK7 | 0.34896009 |
138 | ADRBK2 | 0.34687054 |
139 | IGF1R | 0.34631474 |
140 | ABL1 | 0.30912068 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.58836027 |
2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.62106552 |
3 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.49619484 |
4 | Measles_Homo sapiens_hsa05162 | 2.45046446 |
5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.43843831 |
6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.35017594 |
7 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.17208488 |
8 | DNA replication_Homo sapiens_hsa03030 | 2.15982738 |
9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.09874263 |
10 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.08864835 |
11 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.02476868 |
12 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.00046488 |
13 | Allograft rejection_Homo sapiens_hsa05330 | 1.95725769 |
14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.94479359 |
15 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.82097747 |
16 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.80440561 |
17 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.80196407 |
18 | Base excision repair_Homo sapiens_hsa03410 | 1.78421249 |
19 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.75295450 |
20 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.72765686 |
21 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.70814635 |
22 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.70226620 |
23 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.59043072 |
24 | Mismatch repair_Homo sapiens_hsa03430 | 1.58722567 |
25 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.44667540 |
26 | Legionellosis_Homo sapiens_hsa05134 | 1.44445665 |
27 | Hepatitis B_Homo sapiens_hsa05161 | 1.38675662 |
28 | Influenza A_Homo sapiens_hsa05164 | 1.38166312 |
29 | Pertussis_Homo sapiens_hsa05133 | 1.35499770 |
30 | Platelet activation_Homo sapiens_hsa04611 | 1.31998884 |
31 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.30354356 |
32 | Malaria_Homo sapiens_hsa05144 | 1.28326698 |
33 | Homologous recombination_Homo sapiens_hsa03440 | 1.27801420 |
34 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.24922802 |
35 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.24211552 |
36 | Other glycan degradation_Homo sapiens_hsa00511 | 1.22728786 |
37 | Tuberculosis_Homo sapiens_hsa05152 | 1.22207454 |
38 | Viral myocarditis_Homo sapiens_hsa05416 | 1.17596117 |
39 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.17124443 |
40 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.14333574 |
41 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.13789612 |
42 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.13735214 |
43 | Apoptosis_Homo sapiens_hsa04210 | 1.13721448 |
44 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.12376399 |
45 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.11339010 |
46 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.09541820 |
47 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.07269656 |
48 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.06045769 |
49 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.05465993 |
50 | Shigellosis_Homo sapiens_hsa05131 | 1.04224589 |
51 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.03531755 |
52 | Asthma_Homo sapiens_hsa05310 | 1.01945604 |
53 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.01378465 |
54 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.00816311 |
55 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.99415829 |
56 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.95636178 |
57 | RNA degradation_Homo sapiens_hsa03018 | 0.94796102 |
58 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.91170445 |
59 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.90214144 |
60 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.89189090 |
61 | Hepatitis C_Homo sapiens_hsa05160 | 0.88074713 |
62 | Cell cycle_Homo sapiens_hsa04110 | 0.86566629 |
63 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.85541104 |
64 | Endometrial cancer_Homo sapiens_hsa05213 | 0.84689844 |
65 | Salmonella infection_Homo sapiens_hsa05132 | 0.83832936 |
66 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.83723830 |
67 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.83257421 |
68 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.83211492 |
69 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.81870905 |
70 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.80839097 |
71 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.79990897 |
72 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.79411403 |
73 | HTLV-I infection_Homo sapiens_hsa05166 | 0.77497366 |
74 | Glioma_Homo sapiens_hsa05214 | 0.75806604 |
75 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.74854407 |
76 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.74583671 |
77 | Insulin resistance_Homo sapiens_hsa04931 | 0.74388279 |
78 | Spliceosome_Homo sapiens_hsa03040 | 0.72279911 |
79 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.72208278 |
80 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.71787282 |
81 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.71517610 |
82 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.71262713 |
83 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.70109730 |
84 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.70077709 |
85 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.69507174 |
86 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.68781990 |
87 | Lysosome_Homo sapiens_hsa04142 | 0.68221625 |
88 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.67198944 |
89 | Thyroid cancer_Homo sapiens_hsa05216 | 0.65125894 |
90 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.64420237 |
91 | Focal adhesion_Homo sapiens_hsa04510 | 0.63867982 |
92 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.60387299 |
93 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.60242010 |
94 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.59977602 |
95 | Amoebiasis_Homo sapiens_hsa05146 | 0.57933593 |
96 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.57504427 |
97 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.56649957 |
98 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.55990358 |
99 | Phagosome_Homo sapiens_hsa04145 | 0.54520128 |
100 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.54495948 |
101 | Long-term potentiation_Homo sapiens_hsa04720 | 0.54243308 |
102 | Endocytosis_Homo sapiens_hsa04144 | 0.53270925 |
103 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.52971672 |
104 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.52519203 |
105 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.50639456 |
106 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.50637003 |
107 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.49501062 |
108 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.48740419 |
109 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.48669469 |
110 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.47434610 |
111 | Basal transcription factors_Homo sapiens_hsa03022 | 0.46315655 |
112 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.45730077 |
113 | ABC transporters_Homo sapiens_hsa02010 | 0.45522882 |
114 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.45355109 |
115 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.44727305 |
116 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.44431656 |
117 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.43738548 |
118 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.43558681 |
119 | Ribosome_Homo sapiens_hsa03010 | 0.42914148 |
120 | Prostate cancer_Homo sapiens_hsa05215 | 0.41447171 |
121 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.37120697 |
122 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.35863743 |
123 | Colorectal cancer_Homo sapiens_hsa05210 | 0.33365085 |
124 | Protein export_Homo sapiens_hsa03060 | 0.32808773 |
125 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.32458185 |
126 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.32441185 |
127 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.32163766 |
128 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.31856679 |
129 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.31643122 |